142
Views
3
CrossRef citations to date
0
Altmetric
Clinical focus: Pulmonary and Respiratory Conditions - Original Research

A community study of the risk for obstructive sleep apnea and respiratory inflammation in an adult Chinese population

ORCID Icon, , , &
Pages 531-540 | Received 10 Feb 2021, Accepted 06 Apr 2021, Published online: 15 Apr 2021

References

  • Patel SR. Obstructive sleep apnea. Ann Intern Med. 2019;171:ITC81–ITC96.
  • Laratta CR, Kendzerska T, Carlsten C, et al. Air pollution and systemic inflammation in patients with suspected OSA living in an urban residential area. Chest. 2020;158:1713–1722.
  • Bikov A, Hull JH, Kunos L. Exhaled breath analysis, a simple tool to study the pathophysiology of obstructive sleep apnoea. Sleep Med Rev. 2016;27:1–8.
  • McNicholas WT. Chronic obstructive pulmonary disease and obstructive sleep apnea: overlaps in pathophysiology, systemic inflammation, and cardiovascular disease. Am J Respir Crit Care Med. 2009;180:692–700.
  • Wali SO, Al-Mughales J, Alhejaili F, et al. The utility of proinflammatory markers in patients with obstructive sleep apnea. Sleep Breath. 2020.Online ahead of print.
  • Karamanlı H, Özol D, Ugur KS, et al. Influence of CPAP treatment on airway and systemic inflammation in OSAS patients. Sleep Breath. 2014;18:251–256.
  • Peker Y, Thunström E, Glantz H, et al. Effect of obstructive sleep apnea and CPAP treatment on cardiovascular outcomes in acute coronary syndrome in the RICCADSA trial. J Clin Med. 2020;9:4051.
  • Chirinos JA, Gurubhagavatula I, Teff K, et al. CPAP, weight loss, or both for obstructive sleep apnea. N Engl J Med. 2014;370:2265–2275.
  • Kimoff RJ, Hamid Q, Divangahi M, et al. Increased upper airway cytokines and oxidative stress in severe obstructive sleep apnoea. Eur Respir J. 2011;38:89–97.
  • Sarıman N, Levent E, Cubuk R, et al. Bronchial hyperreactivity and airway wall thickening in obstructive sleep apnea patients. Sleep Breath. 2011;15:341–350.
  • Aihara K, Oga T, Harada Y, et al. Comparison of biomarkers of subclinical lung injury in obstructive sleep apnea. Respir Med. 2011;105:939–945.
  • Feng X, Guo X, Lin J, et al. Risk factors and fraction of exhaled nitric oxide in obstructive sleep apnea in adults. J Int Med Res. 2020;48:300060520926010.
  • Finamore P, Scarlata S, Cardaci V, et al. Exhaled breath analysis in obstructive sleep apnea syndrome: a review of the literature. Medicina (Kaunas). 2019;55:538. .
  • Carpagnano GE, Kharitonov SA, Resta O, et al. Increased 8-isoprostane and interleukin-6 in breath condensate of obstructive sleep apnea patients. Chest. 2002;122:1162–1167.
  • Li Y, Chongsuvivatwong V, Geater A, et al. Exhaled breath condensate cytokine level as a diagnostic tool for obstructive sleep apnea syndrome. Sleep Med. 2009;10:95–103.
  • Qiao H, Wang GF, Zhang H, et al. [The interleukin-6 level in exhaled breath condensate of patients with obstructive sleep apnea-hypopnea syndrome]. Zhonghua Jie He He Hu Xi Za Zhi. 2005;28:364–367.
  • Zagórska W, Grzela K, Kulus M, et al. Nitric oxide, IL-6 and IL-13 are increased in the exhaled breath condensates of children with allergic rhinitis. Acta Paediatr. 2014;103:e148–53.
  • Vergara D, Ávila D, Escobar E, et al. The intake of maqui (Aristotelia chilensis) berry extract normalizes H2O2 and IL-6 concentrations in exhaled breath condensate from healthy smokers - an explorative study. Nutr J. 2015;14:27.
  • Peppard PE, Young T, Barnet JH, et al. Increased prevalence of sleep-disordered breathing in adults. Am J Epidemiol. 2013;177:1006–1014.
  • Senaratna CV, Perret JL, Matheson MC, et al. Validity of the Berlin questionnaire in detecting obstructive sleep apnea: a systematic review and meta-analysis. Sleep Med Rev. 2017;36:116–124.
  • Tan A, Yin JD, Tan LW, et al. Using the Berlin questionnaire to predict obstructive sleep apnea in the general population. J Clin Sleep Med. 2017;13:427–432.
  • Lü XP, Zhang C, Ma J, et al. [Application of Berlin questionnaire in the screening of obstructive sleep apnea hypopnea syndrome]. Zhonghua Jie He He Hu Xi Za Zhi. 2011;34:515–519.
  • Forbes LR, Haczku A. SP-D and regulation of the pulmonary innate immune system in allergic airway changes. Clin Exp Allergy. 2010;40:547–562.
  • Fakih D, Akiki Z, Junker K, et al. Surfactant protein D multimerization and gene polymorphism in COPD and asthma. Respirology. 2018;23:298–305.
  • Sorensen GL. Surfactant Protein D in respiratory and non-respiratory diseases. Front Med (Lausanne). 2018;5:18.
  • Liang S, Li N, Heizhati M, et al. What do changes in concentrations of serum surfactant proteins A and D in OSA mean? Sleep Breath. 2015;19:955–962.
  • Kjeldgaard P, Lykkegaard J, Spillemose H, et al. Multicenter study of the COPD-6 screening device: feasible for early detection of chronic obstructive pulmonary disease in primary care? Int J Chron Obstruct Pulmon Dis. 2017;12:2323–2331.
  • Vandevoorde J, Verbanck S, Schuermans D, et al. FEV1/FEV6 and FEV6 as an alternative for FEV1/FVC and FVC in the spirometric detection of airway obstruction and restriction. Chest. 2005;127:1560–1564.
  • Labor M, Vrbica Ž, Gudelj I, et al. Diagnostic accuracy of a pocket screening spirometer in diagnosing chronic obstructive pulmonary disease in general practice: a cross sectional validation study using tertiary care as a reference. BMC Fam Pract. 2016;17:112.
  • Horváth I, Barnes PJ, Loukides S, et al. A European Respiratory Society technical standard: exhaled biomarkers in lung disease. Eur Respir J. 2017;49:1600965..
  • Huang SG, Li QY. [Prevalence of obstructive sleep apnea-hypopnea syndrome in Chinese adults aged over 30 yr in Shanghai]. Zhonghua Jie He He Hu Xi Za Zhi. 2003;26:268–272.
  • Bradley TD, Floras JS. Obstructive sleep apnoea and its cardiovascular consequences. Lancet. 2009;373:82–93.
  • Kohler M. Why should we care about upper airway inflammation in obstructive sleep apnoea? Eur Respir J. 2016;48:982–983.
  • Vicente E, Marin JM, Carrizo SJ, et al. Upper airway and systemic inflammation in obstructive sleep apnoea. Eur Respir J. 2016;48:1108–1117.
  • Endothelial function in obstructive sleep apnea.Prog Cardiovasc Dis. 2009;51:351-62.
  • Kunos L, Bikov A, Lazar Z, et al. Evening and morning exhaled volatile compound patterns are different in obstructive sleep apnoea assessed with electronic nose. Sleep Breath. 2015;19:247–253.
  • Zhang H, Qiao H, Wang GF. [Hydrogen peroxide is increased after sleep in exhaled breath condensate of patients with obstructive sleep apnea-hypopnea syndrome]. Zhonghua Jie He He Hu Xi Za Zhi. 2006;29:541–544.
  • Bikov A, Galffy G, Tamasi L, et al. Exhaled breath condensate pH is influenced by respiratory droplet dilution. J Breath Res. 2012;6:046002.
  • Colmorten KB, Nexoe AB, Sorensen GL. The dual role of surfactant protein-D in vascular inflammation and development of cardiovascular disease. Front Immunol. 2019;10:2264.
  • Lomas DA, Silverman EK, Edwards LD, et al. Serum surfactant protein D is steroid sensitive and associated with exacerbations of COPD. Eur Respir J. 2009;34:95–102.
  • Lu D, Abulimiti A, Wu T, et al. Pulmonary surfactant-associated proteins and inflammatory factors in obstructive sleep apnea. Sleep Breath. 2018;22:99–107.
  • Lu D, Li N, Yao X, et al. Potential inflammatory markers in obstructive sleep apnea-hypopnea syndrome. Bosn J Basic Med Sci. 2017;17:47–53.
  • Kunos L, Lazar Z, Martinovszky F, et al. Overnight changes in lung function of obese patients with obstructive sleep apnoea. Lung. 2017;195:127–133.
  • Sorensen GL, Husby S, Holmskov U. Surfactant protein A and surfactant protein D variation in pulmonary disease. Immunobiology. 2007;212:381–416.
  • Jawed S, Mannan N, Qureshi MA. association of surfactant protein-D with obesity. J Ayub Med Coll Abbottabad. 2016;28:489–492.
  • Sorensen GL, Hjelmborg JV, Leth-Larsen R, et al. Surfactant protein D of the innate immune defence is inversely associated with human obesity and SP-D deficiency infers increased body weight in mice. Scand J Immunol. 2006;64:633–638.
  • Huang T, Goodman M, Li X, et al. C-reactive protein and risk of obstructive sleep apnea in four US cohorts. Chest. 2021.
  • Hom S, Walsh B, Hunt J. Matrix effect in exhaled breath condensate interferon-gamma immunoassay. J Breath Res. 2008;2:041001.
  • Ng SS, Tam W, Chan TO, et al. Use of Berlin questionnaire in comparison to polysomnography and home sleep study in patients with obstructive sleep apnea. Respir Res. 2019;20:40.
  • Antczak A, Piotrowski W, Marczak J, et al. Correlation between eicosanoids in bronchoalveolar lavage fluid and in exhaled breath condensate. Dis Markers. 2011;30:213–220.
  • Jackson AS, Sandrini A, Campbell C, et al. Comparison of biomarkers in exhaled breath condensate and bronchoalveolar lavage. Am J Respir Crit Care Med. 2007;175:222–227.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.